When cancer returns or treatment stops working: a guide for patients and families

Understand what the result tells you

A new symptom, a raised tumour marker or the words suspicious for recurrence on a scan can be worrying. They do not all mean the same thing. Some findings need comparison with earlier scans, examination, another test or a biopsy before your team can explain them confidently.

Ask the team to state the current position plainly: is recurrence confirmed, strongly suspected or still one possible explanation? If you have only received a report electronically, arrange a discussion rather than interpreting its conclusion alone. Keep a short note of the symptoms, when they began and whether they are changing.

You can say: ‘Please tell me what this result establishes, what it cannot tell us yet and what we are doing next.’ If more information is needed, leave with the next test or review date and a contact for worsening symptoms.

Recurrence, progression and other words you may hear

These words describe different situations. Ask which applies to you and what it means for the next decision. You do not need to memorise them before your appointment.

Recurrence or relapse

Cancer has returned after a period when it had responded to treatment or could not be detected. It can return near its original site or elsewhere.

Local, regional or distant recurrence

Local is at or close to the original site; regional involves nearby tissues or lymph nodes; distant involves a faraway site. Cancer that has spread is still named for its original cancer type. Distant spread is also called metastatic cancer.

Progression

Known cancer is growing or spreading. This may happen during treatment or after a period of control; it does not mean that every treatment option has been exhausted.

Refractory or resistant cancer

Cancer that is not responding to a treatment. Resistance may be present from the start or develop during treatment. Ask which treatment this refers to and what other approaches may be appropriate.

Second primary cancer

A separate new cancer, rather than spread from the first one. Distinguishing the two can change the treatment plan.

Stable disease

Cancer has not changed enough to be described as a response or progression using the assessment being used. In some treatment settings, stability is a useful result.

A manageable plan for the first few days

You may feel pressure to collect opinions, buy tests or decide immediately. First ask what time is safely available. Some problems require prompt treatment; others allow time for clarification and another discussion. There is no single waiting period that is right for everyone.

Choose one trusted adult, if you want, to accompany you and help take notes. Tell the team whether you want the main points first or more detail, and which language helps you understand best. Ask for an interpreter where available rather than relying on a child to explain difficult medical information.

You can ask for help with pain, sickness, sleep or distress while tests and decisions are being arranged. The section on symptom and supportive care explains what to ask for; you do not need a final treatment decision before requesting help.

• Confirm the next appointment, any tests already arranged and who will communicate the results.
• Write down the three questions you most need answered, including any symptom that is affecting daily life.
• Keep taking prescribed medicines as instructed unless the team advises a change. Do not stop a cancer medicine solely because you have read a scan report.
• Ask who to contact during working hours and after hours, and where to go if you cannot reach them.
• Postpone non-essential decisions if you are overwhelmed; ask what must be decided now and what can wait.

Which tests could change the plan?

Tests are chosen to answer specific questions: where the cancer is now, whether a finding is cancer, whether it is the original cancer and which treatment might help. Not everybody needs every scan or another biopsy. Ask what a proposed test could change and what happens if it is inconclusive.

A fresh tissue sample can sometimes confirm the diagnosis or show a change that affects treatment. The likely value must be weighed against the procedure's risks and whether a suitable sample can be obtained. A previous specimen may sometimes provide the information needed.

Biomarkers are features of the cancer, such as certain genes or proteins, that may help guide care. Biomarker testing can identify features relevant to certain treatments or trials. These features can change over time, so repeat testing is useful in selected situations. A result does not guarantee that a matching medicine will work or be available. Ask about the test’s purpose, limitations, reporting time and total cost before agreeing.

If a broad next-generation sequencing (NGS) panel is suggested, ask why it is preferable to a smaller targeted test for this cancer. Request a written estimate covering the sample procedure, test and any further testing. Ask separately about the cost and availability of a treatment the result might suggest. Insurance or government-scheme cover must be checked for the exact test and hospital; an advertised price or a scheme card alone cannot settle this.

Prepare a record folder and a one-page summary

A clear history helps a team understand what has already helped, what caused difficulties and which options remain reasonable. The caregiver toolkit's appointment and record tools can help organise this. A summary should accompany the original reports, rather than replace them.

If you are seeking another opinion, ask the receiving centre exactly what it needs and how to send it securely. Actual scan images may be needed as well as written reports. Leave an uncertain detail marked ‘to confirm’ rather than guessing a dose, diagnosis or date.

• Original diagnosis and pathology reports, later addenda and relevant biomarker results; ask whether slides or tissue blocks are needed.
• Earlier and current scan reports, with accessible images and comparison dates.
• Operations and radiotherapy summaries, and a treatment timeline with medicine names, dates, responses and reasons for stopping.
• Important side effects, hospital admissions, allergies and any treatment alert card.
• Current prescriptions, supplements, recent blood results and other medical conditions.
• The changes you have noticed in walking, self-care, work, eating, sleep and other daily activities.

Tell the team what you most want to protect

Before weighing treatments, take a moment to say what you hope care will help you do. You do not have to choose between wanting more time and wanting that time to be manageable. Tell the team about both, so the options can be discussed in the context of your life.

People facing similar options can reasonably choose differently. You might want the best chance of longer control, more time at home, enough energy for a family event or fewer hospital visits. You may value several things at once. Tell the team which trade-offs are difficult for you.

A helpful opening is: ‘I am willing to accept some side effects if there is a worthwhile chance of benefit, but I am worried about…’ Another is: ‘Before I choose, I need to understand what everyday life might look like with each option.’ Your priorities can change; decisions can be revisited when the situation changes.

Ask for cost and insurance discussions early if affordability could interrupt care. Use Costs, insurance and financial support to prepare questions. Do not buy a medicine or commit to travel on the assumption that a scheme, insurer or assistance programme will cover it.

Use the consultation to build a shared plan

Start by agreeing on the question for this visit. It may be to confirm a recurrence, decide whether the current treatment is still useful or compare the next options. Ask the clinician to separate established facts from reasonable possibilities and remaining uncertainty.

At the end, describe the plan back in your own words: ‘My understanding is that we are waiting for this result, treating this symptom now and meeting again on this date.’ This checks the explanation, not your ability. Ask for a written summary if available.

• What has changed, and compared with which earlier result?
• Is all the cancer progressing, or is the picture mixed? Does that change the recommendation?
• Is another test needed before choosing treatment, and who will act on the result?
• How quickly must a decision be made? Is there time for a second opinion?
• What is the recommendation, why does it fit me, and what reasonable alternatives exist?
• What should I do about current treatment and symptoms while waiting?

Compare what each option could offer you

Some recurrences can be treated with the aim of cure. In other situations, the aim is longer control, symptom relief or both. Ask for the goal in your case rather than inferring it from the treatment name or the word palliative.

The next option could involve local treatment, such as surgery or radiotherapy to a particular area, a different cancer medicine, a clinical trial or a focus on symptom care. Availability of another treatment does not automatically mean it is a good fit. Previous benefit and side effects, current strength and organ function, and your preferences all matter.

If numbers would help, ask for the expected benefit in understandable terms, with its uncertainty. A trial average is not a prediction for one person. Compare hospital visits, side effects, recovery time, independence and out-of-pocket costs as well as the chance of controlling cancer. Use the treatment-choice sheet with your clinician, leaving clinical estimates for them to explain.

If the choices feel like a long list, ask: “Which option would you recommend for me, and why? How does it fit what I have said matters most?” Shared decision-making means discussing a reasoned recommendation together; you are not expected to choose a treatment alone.

When another opinion or a clinical trial may help

A second opinion can help clarify a diagnosis, an important treatment choice or whether specialist review is useful. Ask a specific question and choose expertise relevant to your cancer. It is possible for two careful teams to recommend the same plan; that can still be valuable reassurance. You can also ask whether a multidisciplinary tumour board would help bring the relevant specialists together around the same question.

Ask your current team whether waiting for the review is safe and whether any immediate care should continue. If recommendations differ, ask each team to explain the evidence and assumptions rather than choosing whichever sounds most optimistic. Read when a second opinion helps for a practical record checklist.

A trial may be an option, but eligibility, timing, location and costs need checking. Ask what is known, what remains experimental, what extra visits or tests are required and what happens if you withdraw. A trial is not a promise of benefit. The clinical trials guide explains questions to take to the research team.

Agree how you will know whether the plan is helping

Before starting, continuing or changing treatment, ask how and when its value will be reviewed. The assessment may include symptoms, examination, daily function, blood results or scans. There is no universal scan schedule or tumour-marker rule for all cancers.

Ask what improvement, stability or worsening would mean for the next decision. Some treatment effects complicate interpretation, and the team must interpret the whole picture. With some immunotherapies, an initial apparent worsening on scans can be followed by improvement; this is called pseudoprogression. It must be distinguished from true cancer progression. Do not assume that an unusual scan finding is pseudoprogression or that worsening symptoms should be ignored.

Record the review date, who books it and who will explain the result. Also record the symptoms or side effects that should bring the review forward. If treatment is paused, clarify which medicines continue, who is responsible for follow-up and when the pause will be reconsidered.

Ask for symptom relief and support throughout

Pain, breathlessness, nausea, constipation, sleep problems and anxiety deserve attention now. You do not have to wait for the next cancer treatment to begin. Tell the team what is limiting you and whether the prescribed symptom medicines are helping.

Palliative care can work alongside treatment aimed at cancer control or cure. It supports symptoms, communication and practical or emotional needs; a referral does not by itself mean that you are dying. Ask what services are available locally and how to reach them.

If further cancer treatment is unlikely to offer benefit that matters to you, a plan centred on comfort and daily life remains active care. Ask for a named clinician, medicines and equipment arrangements, an urgent-care plan and support for your caregiver. Stopping an anticancer treatment should never mean being left without a care plan.

Make space for family, feelings and future conversations

Recurrence is not evidence that you failed to think positively or did not try hard enough. It does not automatically mean that the earlier treatment was wrong. Ask for an explanation without accepting blame for the cancer's behaviour.

Choose who receives medical updates and what you want shared. One agreed family contact can reduce repeated calls, but your own questions and preferences should remain central. Ask for a private conversation with the team if family discussions make it difficult to speak openly. Children need simple, honest updates and practical reassurance about who will care for them.

If worry is stopping you sleeping, eating, functioning or attending care, ask about psycho-oncology—the psychological and emotional aspects of cancer care—counselling or other professional support. You can also discuss who you want involved in future decisions and what matters if you become more unwell. Such conversations can sit alongside hope and treatment. Ask the team how to record and review your wishes and who should be involved.

Leave with one clear next step and a written plan

You do not need a complete answer to every question today. You do need a clear next step and a way to obtain help. Put the agreed plan on one page and share it only with the people involved in your care.

• The diagnosis or working explanation is clear, with uncertainties written down.
• Outstanding tests have a purpose, expected reporting date and person responsible for follow-up.
• The urgency and next decision date have been explained.
• Current medicines, new prescriptions and any medicines to stop or continue have been checked.
• Treatment options, goals, burdens and your main priorities have been discussed, or a further discussion is booked.
• Symptoms and caregiver needs have an immediate plan.
• You have working daytime and after-hours contacts and know where to seek urgent care.
• Records, appointments, costs and travel arrangements have an owner; a family member is not silently expected to manage everything.

Check what needs attention before the next appointment

The word recurrence alone does not tell you how urgently treatment must start. Ask your clinician how soon your situation needs a decision. At the same time, urgent symptoms need assessment even while the diagnosis or longer-term plan is being clarified.

Seek emergency care for severe or sudden breathlessness, chest pain, collapse, new confusion or major bleeding. New limb weakness, difficulty walking or a new loss of bladder or bowel control needs urgent assessment, particularly with new back pain. Do not wait for all these symptoms to occur together.

During chemotherapy, a temperature of 38°C (100.4°F) or above needs immediate contact with the treating team or urgent assessment; follow a lower threshold if your unit has given one. Severe illness can need help without a fever. Use your existing treatment alert instructions and do not wait for a routine message reply if you are seriously unwell.

Our fever during chemotherapy guide explains what information to have ready when you call. Use your own unit’s instructions if it has given a lower temperature threshold.

Common questions

Worksheets for this guide

Use only the pages that help. These are optional discussion aids; ask the team to check medical information and keep completed copies securely.

• Your next cancer-care conversation

  Organise confirmed facts, uncertainties, questions and the next steps when cancer returns or treatment may need to change.

  Fill in on this deviceDownload fillable PDF (3 pages)
• Comparing treatment choices

  Compare two clinically relevant options using the same questions, with the patient’s priorities alongside benefit, burdens and uncertainty.

  Fill in on this deviceDownload fillable PDF (4 pages)

Related reading

• How doctors know whether cancer treatment is working
• When a second opinion helps
• Palliative care is not giving up
• Caregiver toolkit: appointments and records
• Understanding tumour markers